» Authors » Michal Cibulka

Michal Cibulka

Explore the profile of Michal Cibulka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 56
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schniederova M, Bobcakova A, Grendar M, Markocsy A, Ceres A, Cibulka M, et al.
Medicina (Kaunas) . 2025 Feb; 61(2). PMID: 40005306
: Immune checkpoint inhibitors such as PD-1 and TIM-3 play an important role in regulating the host immune response and are proposed as potential prognostic markers and therapeutic targets in...
2.
Brodnanova M, Cibulka M, Grendar M, Gondas E, Kolisek M
Int J Mol Sci . 2025 Jan; 25(24. PMID: 39769039
Together with chronic inflammation, disturbed magnesium homeostasis is a factor accompanying chronic disease which thus contributes to a reduced quality of human life. In this study, our objective was to...
3.
Cibulka M, Brodnanova M, Halasova E, Kurca E, Kolisek M, Grofik M
Int J Mol Sci . 2024 Aug; 25(15). PMID: 39125993
Neurodegenerative diseases represent an increasing economic, social, and, above all, medical burden worldwide. The second most prevalent disease in this category is Parkinson's disease, surpassed only by Alzheimer's. It is...
4.
Skerenova M, Cibulka M, Dankova Z, Holubekova V, Kolkova Z, Lucansky V, et al.
Adv Med Sci . 2024 Mar; 69(1):198-207. PMID: 38555007
We present the results of an association study involving hospitalized coronavirus disease 2019 (COVID-19) patients with a clinical background during the 3rd pandemic wave of COVID-19 in Slovakia. Seventeen single...
5.
Markocsy A, Bobcakova A, Petrovicova O, Kapustova L, Malicherova Jurkova E, Schniederova M, et al.
Cureus . 2024 Feb; 16(1):e52941. PMID: 38406025
Background: Common variable immunodeficiency (CVID) is a heterogeneous group of immune disorders. The patients are classified according to the clinical manifestation with the infection-only phenotype (CVID) and CVID with immune...
6.
Grofik M, Cibulka M, Oleksakova J, Sivak S, cierny D, Tatarkova Z, et al.
Gen Physiol Biophys . 2023 Jan; 42(1):77-85. PMID: 36705307
Parkinson's disease (PD) is an oxidative stress-linked neurodegenerative disorder, with the highest prevalence among seniors. The objective of this study were: (1) to analyse levels of following oxidative stress parameters:...
7.
Cibulka M, Brodnanova M, Grendar M, Necpal J, Benetin J, Han V, et al.
Int J Mol Sci . 2022 Feb; 23(3). PMID: 35163527
() SNPs rs11240569 and rs823156 are associated with altered risk for Parkinson's disease (PD), predominantly in Asian populations, and rs708727 has been linked to Alzheimer's disease (AD). In this study,...
8.
Brodnanova M, Hatokova Z, Evinova A, Cibulka M, Racay P
Eur J Pharmacol . 2021 Apr; 902:174073. PMID: 33798597
The aim of our work was to study effect of antidepressant imipramine on both thapsigargin- and tunicamycin-induced ER stress and mitochondrial dysfunction in neuroblastoma SH-SY5Y cells. ER stress in SH-SY5Y...
9.
Skorvanek M, Rizig M, Athanasiou-Fragkouli A, Necpal J, Straka I, Tamas G, et al.
Parkinsonism Relat Disord . 2021 Feb; 83:110-112. PMID: 33561776
No abstract available.
10.
Werner T, Kolisek M, Vormann J, Pilchova I, Grendar M, Struharnanska E, et al.
Magnes Res . 2020 Mar; 32(3):63-71. PMID: 32162607
Background: Low magnesium (Mg) levels are linked to many diseases. Studies suggest that organic salts of Mg are more readily bioavailable than its oxide or inorganic salts used for supplements...